Direct‐to‐consumer genetic testing for factor V Leiden and prothrombin 20210G>A: the consumer experience
Abstract Background Clinical genetic testing for inherited predisposition to venous thromboembolism (VTE) is common among patients and their families. However, there is incomplete consensus about which individuals should receive testing, and the relative risks and benefits. Methods We assessed outco...
Main Authors: | Sarah L. Elson, Nicholas A. Furlotte, Bethann S. Hromatka, Catherine H. Wilson, Joanna L. Mountain, Helen M. Rowbotham, Elizabeth A. Varga, Uta Francke |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2020-11-01
|
Series: | Molecular Genetics & Genomic Medicine |
Online Access: | https://doi.org/10.1002/mgg3.1468 |
Similar Items
-
PREGNANCY AND CHILDBIRTH IN A YOUNG WOMAN WITH CONCOMITANT MUTATION IN LEIDEN AND PROTHROMBIN GENE G20210A
by: D. L. Kapanadze
Published: (2016-06-01) -
Management of pregnancy and labor in female with combination of homozygous Leiden and heterozygous prothrombin G20210A mutations
by: M. O. Arslanbekova, et al.
Published: (2020-04-01) -
Gestational complications of the prothrombin G20210A mutation related to prothrombin activity
by: M. G. Nikolaeva, et al.
Published: (2020-07-01) -
Pregnancy-associated venous thromboembolism in combined heterozygous factor V Leiden and prothrombin G20210A mutations
by: Egle Couto, et al. -
Phenotypic presentation of thrombophilia in double heterozygote for factor v leiden and prothrombin 20210 G>A mutations: Case report
by: Nagorni-Obradović Ljudmila, et al.
Published: (2014-01-01)